Reporting a Population Pharmacokinetic–Pharmacodynamic Study: A Journal’s Perspective

被引:0
|
作者
Kris M. Jamsen
Sarah C. McLeay
Michael A. Barras
Bruce Green
机构
[1] Model Answers Pty Ltd,
[2] Royal Brisbane and Women’s Hospital,undefined
来源
Clinical Pharmacokinetics | 2014年 / 53卷
关键词
Supplementary File; Population Pharmacokinetic Model; Objective Function Value; Visual Predictive Check; Sampling Schedule;
D O I
暂无
中图分类号
学科分类号
摘要
The key purpose of performing pharmacometric research is to aid optimization of drug dosing strategies. The statistical techniques required for this research are advanced, which can make interpretation of results difficult to convey to the target audience if they are unfamiliar with pharmacometric concepts. This article provides a basic guide for authors who wish to publish pharmacometric analyses in peer-reviewed journals. This guide is intended to enhance the readability, reproducibility and understanding of the work for a general readership, which may include clinicians, pharmacists and pharmacometricians. Presentation techniques and examples are offered, as well as a checklist of suggested contents for the manuscript.
引用
收藏
页码:111 / 122
页数:11
相关论文
共 50 条
  • [41] Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients
    Mentré, F
    Pousset, F
    Comets, E
    Plaud, B
    Diquet, B
    Montalescot, G
    Ankri, A
    Mallet, A
    Lechat, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (01) : 64 - 78
  • [42] A Pharmacokinetic and Pharmacodynamic Study of Oral Dexmedetomidine
    Chamadia, Shubham
    Pedemonte, Juan C.
    Hobbs, Lauren E.
    Deng, Hao
    Nguyen, Sarah
    Cortinez, Luis I.
    Akeju, Oluwaseun
    ANESTHESIOLOGY, 2020, 133 (06) : 1223 - 1233
  • [43] Strategies for developing Alzheimer's disease treatments: application of population pharmacokinetic and pharmacodynamic models
    Kang, Dong Wook
    Cho, Seok-jin
    Choi, Go-Wun
    Cho, Hea-Young
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2022, 52 (05) : 519 - 538
  • [44] Population pharmacokinetic/pharmacodynamic analysis for oxcarbazepine in paediatric patients
    Souppart, C
    Nedelman, J
    EPILEPSIA, 2005, 46 : 118 - 118
  • [45] POPULATION PHARMACOKINETIC-PHARMACODYNAMIC METHODOLOGY AND APPLICATIONS - A BIBLIOGRAPHY
    YUH, L
    BEAL, S
    DAVIDIAN, M
    HARRISON, F
    HESTER, A
    KOWALSKI, K
    VONESH, E
    WOLFINGER, R
    BIOMETRICS, 1994, 50 (02) : 566 - 575
  • [46] Exploring inductive linearization in population pharmacokinetic and pharmacodynamic models
    Fidler, Matt
    Xiong, Yuan
    Schoemaker, Rik
    Wilkins, Justin
    Trame, Mirjam N.
    Post, Teun
    Hooijmakers, Richard
    Wang, Wenping
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S116 - S116
  • [47] An Approach for Identifiability of Population Pharmacokinetic-Pharmacodynamic Models
    Shivva, V.
    Korell, J.
    Tucker, I. G.
    Duffull, S. B.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2013, 2 (06):
  • [48] Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships for docetaxel
    Bruno, R
    Vivier, N
    Veyrat-Follet, C
    Montay, G
    Rhodes, GR
    INVESTIGATIONAL NEW DRUGS, 2001, 19 (02) : 163 - 169
  • [49] Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects
    Chan, Phyllis
    Mould, Diane R.
    AbuTarif, Malaz
    Wen, Jessica
    Chang, Mei-Hwei
    Emerick, Karan
    Reynolds, Laurie
    Bertz, Richard
    Bifano, Marc
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S104 - S104
  • [50] Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships for Docetaxel
    René Bruno
    Nicole Vivier
    Christine Veyrat-Follet
    Guy Montay
    Gerald R. Rhodes
    Investigational New Drugs, 2001, 19 : 163 - 169